Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.06.04 | Reproduction: Female and PCOS | ECE2015

Phenotypic characteristic of type 1 diabetic women with polycystic ovary syndrome

Lebkowska Agnieszka , Adamska Agnieszka , Karczewska-Kupczewska Monika , Nikolajuk Agnieszka , Otziomek Elzbieta , Milewski Robert , Wolczynski Slawomir , Gorska Maria , Kowalska Irina

Introduction: The prevalence of polycystic ovary syndrome (PCOS) is increased in women with type 1 diabetes (T1DM) in comparison to the general population. It has been suggested that exogenous insulin administered to T1DM women in supraphysiological doses could act as co-gonadotropin and lead to disturbances observed in PCOS.Aim: The aim of this study was to evaluate the phenotypic characteristic and differences between diabetic women with PCOS (T1DM+PCO...

ea0037gp.06.08 | Reproduction: Female and PCOS | ECE2015

Plasma brain derived neurotrophic factor is decreased in women with polycystic ovary syndrome and related to the markers of endothelial dysfunction

Kowalska Irina , Karczewska-Kupczewska Monika , Adamska Agnieszka , Nikolajuk Agnieszka , Lebkowska Agnieszka , Otziomek Elzbieta , Wolczynski Slawomir , Straczkowski Marek

Introduction: Brain derived neurotrophic factor (BDNF) is a neurotrophin which plays a role in neuronal growth and differentiation. Decreased level of BDNF is supposed to play a role in the pathogenesis of the neurodegenerative diseases. Recent data indicate that BDNF could be also involved in angiogenesis. Several lines of evidence support the role of BDNF in glucose metabolism. The decreased level of BDNF are observed in obesity and type 2 diabetes mellitus. Polycystic ovary...

ea0035p663 | Female reproduction | ECE2014

Plasma adhesion molecules concentrations in women with type 1 diabetes mellitus and polycystic ovary syndrome

Lebkowska Agnieszka , Karczewska-Kupczewska Monika , Nikolajuk Agnieszka , Adamska Agnieszka , Otziomek Elzbieta , Wolczynski Slawomir , Gorska Maria , Kowalska Irina

Introduction: Polycystic ovary syndrome (PCOS) and type 1 diabetes (T1DM) are accompanied by an increased risk of cardiovascular complications. The higher prevalence of PCOS in T1DM was reported and thus T1DM women with PCOS exhibit a higher risk of cardiovascular diseases. Soluble E-selectin (sE-selectin) and intercellular adhesion cell molecule-1 (sICAM-1) are considered as an early markers of atherosclerosis.Aim: We aimed to evaluate plasma levels of ...

ea0022p152 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Relationship between serum IL-12 and p40 subunit concentrations and lipid parameters in obese subjects

Nikolajuk Agnieszka , Kowalska Irina , Adamska Agnieszka , Karczewska-Kupczewska Monika , Otziomek Elzbieta , Lebkowska Agnieszka , Gorska Maria , Straczkowski Marek

Numerous studies indicate an association between low-grade chronic inflammation and predisposition to type 2 diabetes and atherosclerosis. IL-12 is a proinflammatory cytokine with proatherogenic properties. IL-12 is a disulfide-linked, 70 kDa (p70) heterodimeric glycoprotein composed of a 40 kDa (p40) subunit and a 35 kDa (p35) subunit. Many data reported higher levels of p40 subunit than total IL-12. The aim of the present study was to estimate serum IL-12 and p40 subunit in ...

ea0022p493 | Female reproduction | ECE2010

Inflammatory markers, adiponectin and metabolic characteristics in different phenotypes of polycystic ovary syndrome

Kowalska Irina , Karczewska-Kupczewska Monika , Adamska Agnieszka , Nikolajuk Agnieszka , Lebkowska Agnieszka , Wolczynski Slawomir , Gorska Maria , Straczkowski Marek

Polycystic ovary syndrome (PCOS) is heterogeneous disorder leading to infertility. The introduction of Rotterdam criteria creates different PCOS phenotypes, i.e. hyperandrogenic anovulatory with (A) and without (B) polycystic ovaries (PCO) morphology in ultrasonography (usg), hyperandrogenic ovulatory with PCO morphology in usg (C), non-hyperandrogenic anovulatory with PCO morphology in usg (D). In PCOS insulin resistance might be involved in the development of endocrine and m...

ea0022p690 | Obesity | ECE2010

Serum fibroblast growth factor 21 in human obesity: regulation by hyperinsulinemia and relationship with glucose and lipid oxidation

Straczkowski Marek , Karczewska-Kupczewska Monika , Adamska Agnieszka , Nikolajuk Agnieszka , Lebkowska Agnieszka , Otziomek Elzbieta , Gorska Maria , Kowalska Irina

Fibroblast growth factor 21 (FGF21) might increase glucose uptake in adipocytes and reduce plasma glucose and triglycerides in animal models of diabetes. The aim of the present study was to assess serum FGF21 concentration in lean and obese subjects, its regulation by hyperinsulinemia and relationship with insulin sensitivity and glucose and lipid oxidation. We examined 76 subjects with normal glucose tolerance, 36 lean (BMI <25 kg/m2) and 39 overweight or obese...

ea0016p531 | Obesity | ECE2008

Metabolic syndrome and endothelial dysfunction in women with polycystic ovary syndrome – relationship with insulin sensitivity

Kowalska Irina , Kozlowska Agnieszka , Straczkowski Marek , Karczewska-Kupczewska Monika , Adamska Agnieszka , Nikolajuk Agnieszka , Wolczynski Slawomir , Gorska Maria

Polycystic ovary syndrome (PCOS) is a main cause of women infertility. There are data suggesting an increased risk for cardiovascular disease in PCOS. Insulin resistance might play a role in the pathogenesis of PCOS and its metabolic complications. The aim of the study was to asses the prevalence of The National Cholesterol Education Program (NCEP)-defined metabolic syndrome (MS) in women with PCOS in relation to insulin resistance and endothelial dysfunction – soluble E-...

ea0065p312 | Neuroendocrinology | SFEBES2019

A case of retroperitoneal fibrosis on low dose Cabergoline

Jarzynska Agnieszka , Khan Huma Humayun , Chandran Shanthi

66 year old patient was diagnosed with macroprolactinoma and started on treatment with Cabergoline at a dose 250 μg twice weekly. Initial echocardiogram was normal and CT chest showed clear lung fields except mild left upper zone consolidation. During a routine follow up appointment 8 months after the initiation of treatment, the blood tests showed abnormal renal function and prolactin level was controlled. CT KUB showed features suggestive of retroperitoneal fibrosis lea...

ea0037ep175 | Reproduction, endocrine disruptors and signalling | ECE2015

Endocrine disorders in women with Turner syndrome

Zwolak Agnieszka , Dabrowska Anna , Tarach Jerzy

Introduction: Turner syndrome (TS) is the most common chromosomal abnormality in women. It occurs in 1/2500 to 1/3000 live-born females and results from a total or partial absence of the X chromosome. The clinical manifestations are diverse and TS is accompanied by multiple medical problems.Methods: We analysed retrospectively six cases of women with TS aged 20–66 years, treated at Endocrinology Department between 2003 and 2014, to describe endocrin...

ea0037ep1079 | Thyroid (non-cancer) | ECE2015

Multiple disease associations in autoimmune polyglandular syndromes

Dabrowska Anna , Zwolak Agnieszka , Tarach Jerzy

Introduction: Autoimmune polyglandular syndromes (APS) are a heterogeneous group of disorders characterised by autoimmune activity against endocrine and non-endocrine organs. APS type depends on the combination of the diseases (APS1, APS2, and APS3).Methods: The study was conducted in 89 patients (70F and 19M) with APS aged mean 50.00±14.80 years, treated at Endocrinology Department between 2003 and 2015. We analysed clinical manifestations, results...